Joel S. Schuman

Joel S. Schuman, MD, FACS is Professor of Ophthalmology, the Kenneth L. Roper Endowed Chair, Vice Chair for Research Innovation, co-director of the Glaucoma Service at Wills Eye Hospital, Professor of Biomedical Engineering at Drexel University School of Biomedical Engineering, Science and Health Systems, Collaborative Community of Ophthalmic Imaging (CCOI) president, and American Glaucoma Society (AGS) Foundation advisory board chair.

Prior to arriving at NYU in 2016, he was Distinguished Professor and Chairman of Ophthalmology, Eye and Ear Foundation Endowed Chair in Ophthalmology, Director of UPMC Eye Center (2003-2016) and before that was at Tufts University 1991–2003, where he was Residency Director (1991-1999) and Glaucoma and Cataract Service Chief (1991-2003).

Dr. Schuman and his colleagues were first to identify a molecular marker for human glaucoma, published in Nature Medicine in 2001.

Continuously funded by the National Eye Institute as a principal investigator since 1995, he is an inventor of optical coherence tomography (OCT), used world-wide for ocular diagnostics.

Joel Schuman, along with Eric Swanson, James Fujimoto, Carmen Puliafito, Charles Lin and David Huang, invented the optical coherence tomography (OCT) technology.

It is one of the tools available for early detection of eye diseases such as glaucoma, along with macular degeneration and diabetic retinopathy.

Joel S. Schuman, MD, FACS , Professor of Ophthalmology, the Kenneth L. Roper Endowed Chair, Vice Chair for Research Innovation and co-director of the Glaucoma Service at Wills Eye Hospital